Literature DB >> 17700424

Effect of Lactobacillus rhamnosus GG in persistent diarrhea in Indian children: a randomized controlled trial.

Sriparna Basu1, Mridula Chatterjee, Sutapa Ganguly, Pranab Kumar Chandra.   

Abstract

AIM: To evaluate the role of Lactobacillus rhamnosus GG (LGG) as probiotic in persistent diarrhea (PD) in children of North Bengal, India.
SETTING: Hospital-based study.
DESIGN: Randomized, double-blind controlled trial. PATIENTS AND METHODS: All patients of PD admitted over a period of 2 years were included in the study as per predefined inclusion criteria. They were randomized to receive oral rehydration solution (ORS) alone, or ORS plus LGG powder containing 60 million cells, twice daily for a minimum period of 7 days or till diarrhea has stopped along with correction of dehydration with ORS and/or intravenous fluids as per WHO protocol and antibiotics in culture positive patients. The duration and frequency of purge and vomiting were studied. Data were analyzed by SPSS-10 software. Statistical significance was calculated by Student t test and chi2 test.
RESULTS: The study comprised of 235 patients randomized into 2 groups, cases (117) and controls (118). Both the groups were similar with respect to age, number of breastfed infants, presentation with dehydration, degree of protein energy malnutrition, and distribution of infections. Stool culture was positive in 90 (38.3%) patients, Escherichia coli being the commonest organism followed by Shigella spp. and Clostridium difficile. The mean duration of diarrhea was significantly lower in the cases than in controls (5.3 vs. 9.2 d). The average duration of hospital stay was also significantly lesser in cases. No complication was observed from the dose of LGG used.
CONCLUSIONS: LGG (dose of 60 million cells) could decrease the frequency and duration of diarrhea and vomiting and reduced hospital stay in patients of PD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17700424     DOI: 10.1097/01.mcg.0000248009.47526.ea

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  16 in total

Review 1.  Probiotics, enteric and diarrheal diseases, and global health.

Authors:  Geoffrey A Preidis; Colin Hill; Richard L Guerrant; B S Ramakrishna; Gerald W Tannock; James Versalovic
Journal:  Gastroenterology       Date:  2010-11-12       Impact factor: 22.682

2.  [Lactobacillus rhamnosus GG conditioned medium prevents E. coli meningitis by inhibiting nuclear factor-κB pathway].

Authors:  Qing Zeng; Xiao-Long He; Han-Sheng Xiao; Lei Du; Yu-Jing Li; Le-Cheng Chen; Hui-Wen Tian; Sheng-He Huang; Hong Cao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-01-20

Review 3.  Probiotics for treating persistent diarrhoea in children.

Authors:  Guillermo Bernaola Aponte; Carlos Alfonso Bada Mancilla; Nilton Yhuri Carreazo; Raúl Alberto Rojas Galarza
Journal:  Cochrane Database Syst Rev       Date:  2013-08-20

Review 4.  Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

5.  Probiotics in the treatment of acute rotavirus diarrhoea. A randomized, double-blind, controlled trial using two different probiotic preparations in Bolivian children.

Authors:  Giuseppe Grandy; Marcos Medina; Richard Soria; Carlos G Terán; Magdalena Araya
Journal:  BMC Infect Dis       Date:  2010-08-25       Impact factor: 3.090

6.  Prebiotic and probiotic fortified milk in prevention of morbidities among children: community-based, randomized, double-blind, controlled trial.

Authors:  Sunil Sazawal; Usha Dhingra; Girish Hiremath; Archana Sarkar; Pratibha Dhingra; Arup Dutta; Priti Verma; Venugopal P Menon; Robert E Black
Journal:  PLoS One       Date:  2010-08-13       Impact factor: 3.240

7.  Are probiotics a feasible intervention for prevention of diarrhoea in the developing world?

Authors:  Neerja Hajela; Gopinath B Nair; Nirmal K Ganguly
Journal:  Gut Pathog       Date:  2010-08-29       Impact factor: 4.181

8.  Lactobacillus rhamnosus GG Suppresses Meningitic E. coli K1 Penetration across Human Intestinal Epithelial Cells In Vitro and Protects Neonatal Rats against Experimental Hematogenous Meningitis.

Authors:  Sheng-He Huang; Lina He; Yanhong Zhou; Chun-Hua Wu; Ambrose Jong
Journal:  Int J Microbiol       Date:  2008-11-24

9.  Effects of dietary inactivated probiotics on growth performance and immune responses of weaned pigs.

Authors:  Joowon Kang; Jeong Jae Lee; Jin Ho Cho; Jeehwan Choe; Hyunjin Kyoung; Sung Hun Kim; Hyeun Bum Kim; Minho Song
Journal:  J Anim Sci Technol       Date:  2021-05-31

10.  High protective efficacy of rice bran against human rotavirus diarrhea via enhancing probiotic growth, gut barrier function, and innate immunity.

Authors:  Xingdong Yang; Erica Twitchell; Guohua Li; Ke Wen; Mariah Weiss; Jacob Kocher; Shaohua Lei; Ashwin Ramesh; Elizabeth P Ryan; Lijuan Yuan
Journal:  Sci Rep       Date:  2015-10-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.